Atlas Trials

A Study to Evaluate Drug-drug Interactions and Safety Between "BR3006-1", "BR3006-2", and "BR3006-3" in Healthy Volunteers

Clinical trial NCT05951946 · COMPLETED

Trial details

NCT number
NCT05951946
Sponsor
Boryung Pharmaceutical Co., Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2023-07-22
Primary completion
2023-09-11
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.